Literature DB >> 30579570

Successful treatment with ribavirine for chronic hepatitis E in chronic lymphocytic leukemia treated with Ibrutinib.

Laurys Boudin1, Matthieu Patient2, Precilla Tsitsi Nding Tsogou3, Emilie Roméo3, Jean-Sébastien Bladé3, Jean-Pierre de Jauréguiberry2.   

Abstract

Entities:  

Keywords:  Chronic hepatitis E; Chronic lymphocytic leukemia; Ibrutinib; Ribavirine

Mesh：

Substances：

Year:  2018        PMID： 30579570     DOI： 10.1016/j.bulcan.2018.11.011

Source DB:  PubMed          Journal:  Bull Cancer        ISSN： 0007-4551            Impact factor:   1.276


× No keyword cloud information.
  2 in total

1.  Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment.

Authors:  Bernhard Schlevogt; Volker Kinast; Julia Reusch; Andrea Kerkhoff; Dimas Praditya; Daniel Todt; Hartmut H Schmidt; Eike Steinmann; Patrick Behrendt
Journal:  Pathogens       Date:  2019-08-22

2.  Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients.

Authors:  Caroline Protin; Florence Abravanel; Laurent Alric; Suzanne Tavitian; Lucie Obéric; Jacques Izopet; Guillaume Martin-Blondel; Loic Ysebaert
Journal:  Open Forum Infect Dis       Date:  2019-07-28       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.